statistiche ricercatore

CLEMENTI, MASSIMO

Distribuzione geografica

Continente	#
EU - Europa	1.436
NA - Nord America	1.114
AS - Asia	1.082
SA - Sud America	153
AF - Africa	18
OC - Oceania	2
Totale	3.805

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	1.055
IT - Italia	1.000
SG - Singapore	552
HK - Hong Kong	213
CN - Cina	187
BR - Brasile	143
GB - Regno Unito	106
IE - Irlanda	76
DE - Germania	72
RU - Federazione Russa	71
CA - Canada	32
IN - India	31
FI - Finlandia	29
VN - Vietnam	28
MX - Messico	24
JP - Giappone	17
BD - Bangladesh	13
PL - Polonia	13
NL - Olanda	11
AT - Austria	10
FR - Francia	10
ES - Italia	9
TR - Turchia	9
BE - Belgio	7
IQ - Iraq	7
ZA - Sudafrica	7
LT - Lituania	6
CH - Svizzera	5
KE - Kenya	5
AE - Emirati Arabi Uniti	4
SA - Arabia Saudita	4
SE - Svezia	4
AR - Argentina	3
JO - Giordania	3
AU - Australia	2
CL - Cile	2
EG - Egitto	2
KR - Corea	2
LB - Libano	2
MA - Marocco	2
PK - Pakistan	2
UA - Ucraina	2
BG - Bulgaria	1
BY - Bielorussia	1
BZ - Belize	1
CG - Congo	1
CI - Costa d'Avorio	1
CO - Colombia	1
CR - Costa Rica	1
DK - Danimarca	1
EC - Ecuador	1
GE - Georgia	1
ID - Indonesia	1
IL - Israele	1
IR - Iran	1
KZ - Kazakistan	1
MY - Malesia	1
PY - Paraguay	1
QA - Qatar	1
RS - Serbia	1
SK - Slovacchia (Repubblica Slovacca)	1
SY - Repubblica araba siriana	1
TT - Trinidad e Tobago	1
UY - Uruguay	1
VE - Venezuela	1
Totale	3.805

Salva come PNG Salva come JPEG

Città	#
Milan	678
Singapore	272
Hong Kong	212
Ashburn	184
Beijing	121
Dallas	97
Chicago	91
Boardman	85
Dublin	76
London	75
Los Angeles	56
Rome	55
The Dalles	55
Munich	27
Washington	27
Ogden	26
New York	25
Brooklyn	20
Helsinki	19
Seattle	19
Santa Clara	17
Varese	17
Mexico City	16
Tokyo	16
Como	13
Warsaw	13
Council Bluffs	12
San Francisco	12
Chennai	11
Toronto	11
Frankfurt am Main	10
Montreal	10
São Paulo	10
Ho Chi Minh City	9
Nuremberg	8
Orem	8
Vienna	8
Atlanta	7
Boston	7
Brussels	7
Denver	7
Pune	7
Ankara	6
Hanoi	6
Johannesburg	6
Phoenix	6
Poplar	6
Amsterdam	5
Dhaka	5
Düsseldorf	5
Falkenstein	5
Magnago	5
Nairobi	5
Pittsburgh	5
Querétaro	5
Rio de Janeiro	5
Belo Horizonte	4
Berlin	4
Bodio Lomnago	4
Cernusco sul Naviglio	4
Chiswick	4
Mumbai	4
New Delhi	4
Salt Lake City	4
Sulmona	4
Turku	4
Vancouver	4
West Jordan	4
Amman	3
Blumenau	3
Campinas	3
Detroit	3
Fortaleza	3
Goiânia	3
Houston	3
Lappeenranta	3
Paris	3
Shanghai	3
Stockholm	3
Assago	2
Baghdad	2
Baltimore	2
Bismarck	2
Boituva	2
Bologna	2
Brasília	2
Campina Grande	2
Cesa	2
Charlotte	2
Curitiba	2
Dulles	2
Fayetteville	2
Greensboro	2
Guiyang	2
Haiphong	2
Honolulu	2
Hounslow	2
Hải Dương	2
Indianapolis	2
Jatai	2
Totale	2.654

Salva come PNG Salva come JPEG

Nome	#
A biologically-validated HCV E1E2 heterodimer structural model	96
A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes	87
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine	85
Clinical characterization and whole genome sequence-based typing of two cases of endophthalmitis due to Listeria monocytogenes	82
Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections	82
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools	79
Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study)	77
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs	76
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein	74
Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients	72
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses	71
A case of psoriatic arthritis triggered by SARS-CoV-2 infection	71
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion?	69
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes	67
Autoimmune hepatitis and occult HCV infection: A prospective single-centre clinical study	67
Identification of a novel mutation involved in colistin resistance in Klebsiella pneumoniae through Next-Generation Sequencing (NGS) based approaches	66
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome	65
Anti-hepatitis C virus E2 (HCV/E2) glycoprotein monoclonal antibodies and neutralization interference	65
Differential composition of vaginal microbiome, but not of seminal microbiome, is associated with successful intrauterine insemination in couples with idiopathic infertility: A prospective observational study	64
Answer to photo quiz: Streptococcus pneumoniae	64
Heterosubtypic protection conferred by the human monoclonal antibody PN-SIA28 against influenza A virus lethal infections in mice	61
Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2	61
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19	61
Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies	61
A human stem cell-derived neurosensory–epithelial circuitry on a chip to model herpes simplex virus reactivation	60
Viral respiratory pathogens and lung Injury	60
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials	59
Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens	58
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases	57
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects	57
The interferon landscape along the respiratory tract impacts the severity of COVID-19	57
JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes?	55
Hepatitis C virus (HCV) infection may elicit neutralizing antibodies targeting epitopes conserved in all viral genotypes	55
Very high SARS-CoV-2 load at the emergency department presentation strongly predicts the risk of admission to the intensive care unit and death	54
Risks of "blind" automated identification systems in medical microbiology	53
Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemia	53
Microbiome markers are early predictors of acute GvHD in allogeneic hematopoietic stem cell transplant recipients	53
Combined prophylactic and therapeutic use maximizes hydroxychloroquine anti-SARS-CoV-2 effects in vitro	52
Possible future monoclonal antibody (mAb)-based therapy against arbovirus infections	52
Enteric microbiome markers as early predictors of clinical outcome in allogeneic hematopoietic stem cell transplant (allo-HSCT): results of a prospective study in adult patients	52
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects	49
Characterization of four major human B-cell epitopes on the surface of HCV E2 glycoprotein by generation of human monoclonal Fab from phage display antibody librariesis	49
Molecular signatures of hepatitis C virus (HCV)-induced type II mixed cryoglobulinemia (MCII)	49
Chimeric antigen receptor (CAR)-redirected T cells: is there a place for them in infectious diseases?	48
Diverging effects of human recombinant anti-hepatitis C virus (HCV) antibody fragments derived from a single patient on the infectivity of a vesicular stomatitis Virus/HCV pseudotype	48
Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies	47
Structural and antigenic definition of hepatitis C virus E2 glycoprotein epitopes targeted by monoclonal antibodies	46
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge	45
IFCC interim guidelines on molecular testing of SARS-CoV-2 infection	43
Characterization of two human monoclonal anti-E2/HCV antibodies for potential application in prevention and treatment of HCV infection	42
Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle	41
Divergent Trends of Anti-JCPyV Serum Reactivity and Neutralizing Activity in Multiple Sclerosis (MS) Patients during Treatment with Natalizumab	40
Virus-induced preferential antibody gene-usage and its importance in humoral autoimmunity	39
Role and potential therapeutic use of antibodies against herpetic infections	39
HCV Proteins and Immunoglobulin Variable Gene (IgV) Subfamilies in HCV-Induced Type II Mixed Cryoglobulinemia: A Concurrent Pathogenetic Role	37
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection	36
Modulation of epitope-specific anti-hepatitis C virus E2 (Anti-HCV/E2) antibodies by anti-viral treatment	35
Lower nasopharyngeal viral load during the latest phase of COVID-19 pandemic in a Northern Italy University Hospital	35
Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: Epitope definition and implications in risk stratification of patients under natalizumab therapy	34
Perspectives for the utilization of neutralizing human monoclonal antibodies as anti-HCV drugs	34
Photo quiz: Neurological symptoms in a 74-year-old diabetic woman admitted to the emergency room	33
Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin	31
Nanosphere's Verigene (R) System to detect Multidrug-Resistant Gram-negative Bacterial Outbreak: a prospective study in 60 patients	30
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines	30
Human Monoclonal Antibody able to nneutralize a broad range of H1 and H3 subtype influenza A viruses	30
IFCC interim guidelines on biochemical/hematological monitoring of COVID-19 patients	29
Rational dosing strategies of colistin: what about resistance?	28
Longitudinal microbiome profile associates with the risk of major transplant-related complications in allogeneic HSCT recipients	28
Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site on gp120SITE ON GP120	27
Facing the Rising Tide of Multidrug Resistant Gram-Negative Pathogens in Allogeneic HSCT with Nanosphere's Verigene((R)) System	26
Interferon β-1a (IFNβ-1a) in COVID-19 patients (INTERCOP): study protocol for a randomized controlled trial	25
Oral and Fecal Microbiota in Lynch Syndrome	24
Evaluation of a synergistic interactions of anti-E2/HCV monoclonal antibodies	23
Microbiological Diagnosis of Sepsis: The Confounding Effects of a “Gold Standard”	23
Molecular Cloning of a Human Monoclonal Antibody neutralizing a broad range of H1 subtype influenza virus including swine-origin influenza virus (S-OIV)	22
Rapid Molecular Detection of Pathogens in 516 Consecutive Haematological Patients with Febrile Neutropenia	22
Improving the Diagnostic Algorithm for Sepsis: Adjuvant Role of SeptiFast in 491 Consecutive Hematological Patients	21
Definition of biological activity and quantitation of different families of human anti-HCV/E2 antibodies by generation of human recombinant anti-E2 monoclonal Fab by phage display combinatorial repertoire library	21
RAPID MOLECULAR DETECTION OF PATHOGENS IN 1941 BLOOD SAMPLES FROM 516 CONSECUTIVE PATIENTS WITH FEBRILE NEUTROPENIA	21
Molecular dissection of the IGM/K antibody repertoire in an HCV-infected patient with cryoglobulinemia	20
Molecular dissection of the human humoral response against HCV E2 glycoprotein by cloning of the antibody repertoire in phage display combinatorial vectors	18
Multiplex PCR-based assay (SeptiFast) for rapid detection of pathogens in febrile neutropenia: results in 273 consecutive patients	18
Molecular Diagnosis of Scedosporium apiospermum Keratitis	17
Totale	4.013

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	27.461
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	27.461

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2022/2023	232	0	0	0	0	0	0	0	0	123	71	20	18
2023/2024	1.288	163	195	164	256	300	87	7	25	35	35	9	12
2024/2025	1.248	9	38	262	62	46	68	55	57	155	75	92	329
2025/2026	1.245	288	168	156	390	203	40	0	0	0	0	0	0
Totale													4.013